At ChatDok, research is not separate from healthcare delivery. From conversational AI and remote monitoring to multicenter clinical trials and emerging digital-twin technology, our goal is to translate advanced AI into continuous, personalized, and clinically responsible healthcare.

Evaluating an AI-assisted digital chronic care platform combining remote monitoring, patient engagement, and physician oversight in heart failure and coronary artery disease.
Healthcare AI cannot be evaluated by model performance alone. It must work with patients, clinicians, clinical workflows, healthcare data, interoperability requirements, and real-world constraints.
Multimodal AI, conversational AI, predictive analytics, medical reasoning, remote monitoring, and specialized clinical AI components for continuous cardiovascular care.
Guardrails, validation pipelines, hallucination control, monitoring, and human oversight.
Clinical validation, prospective evaluation, randomized controlled trials, and evidence generation.
EHR integration, longitudinal patient data, interoperability, privacy, and scalable digital care workflows.
New approaches such as personalized modeling and digital twins that can support the next generation of clinical decision-making.
Cura is ChatDok's AI infrastructure for healthcare. Rather than relying on a single general-purpose model, the architecture combines specialized AI components designed for different clinical and operational tasks. The current Cura 2.1 architecture uses a 2.7T+ parameter constellation framework together with specialized support models and deterministic safeguards. The objective is not simply to build a larger model. It is to build an AI system that can operate responsibly within healthcare workflows.

Generative AI introduces significant opportunities in healthcare — and significant risks. ChatDok's research therefore places safety and reliability at the center of the platform architecture.
Define what the system can and cannot do within a healthcare context.
Support AI outputs with structured validation and medically grounded information.
Develop methods to reduce unsupported or misleading medical outputs.
Use controlled logic and predefined constraints around sensitive clinical workflows.
Continuously evaluate AI behavior across relevant healthcare scenarios.
Keep appropriate clinical decisions within the responsibility of qualified healthcare professionals.

Our work on medical AI safety includes research into robust hallucination control for generative AI. We investigate how healthcare AI systems can better distinguish between:
This is particularly important when AI is used in patient-facing or clinically relevant environments.
Peer-reviewed technical methodology for deterministic medical verification and strict hallucination mitigation pipelines in clinical LLMs.
Read Case Study PaperHealthcare AI ultimately needs evidence in real patients and real clinical environments. ChatDok is therefore building an evidence base through clinical research and validation programs across its platform.
Testing technology within actual healthcare workflows rather than isolated technical demonstrations.
Measuring how AI-supported care performs over time.
Evaluating clinical interventions against predefined outcomes where appropriate.
Understanding usability, engagement, workflow impact, and adoption alongside clinical measures.
Where appropriate, evaluating outcomes such as utilization, adherence, follow-up workload, and healthcare resource use.
ChatDok-Heart is our flagship clinical research program evaluating physician-led, AI-assisted continuous cardiovascular care for patients with heart failure and coronary artery disease. A multicenter, randomized, controlled trial is evaluating ChatDok-Heart plus usual care versus usual care alone in patients with heart failure and coronary artery disease.
The study evaluates patient-centered cardiovascular outcomes, including KCCQ-12 Overall Summary Score in heart failure and SAQ-7 Summary Score in coronary artery disease, alongside blood-pressure control, LDL-C control, medication adherence, patient self-management, healthcare utilization, and earlier clinician review of clinically relevant deterioration.

Traditional chronic disease management often relies on periodic clinical encounters. Our research explores what becomes possible when patients can remain digitally connected to their care journey between those encounters.
Combining longitudinal patient data, symptoms, vital signs, adherence patterns, and other relevant signals to identify patients at risk of cardiovascular deterioration within a 7–30 day horizon and support earlier clinical review.
Clinical evidence is essential to answering it.
ChatDok is exploring a personalized cardiac digital twin designed to model individual cardiovascular dynamics and support clinical decision-making.
The long-term vision is to create computational models capable of representing an individual's cardiovascular state and exploring how that state may respond to different interventions.
This technology remains in research and development and is distinct from the currently deployed ChatDok products.

Our research programs are designed with translation in mind. The pathway is:
Develop new AI methods, clinical models, and healthcare technologies.
Test performance, safety, usability, and clinical relevance.
Connect validated technology with real healthcare workflows and infrastructure.
Measure clinical, operational, patient, and economic outcomes.
Bring validated capabilities into healthcare environments.
Use real-world evidence to continuously improve the system.
Research → Validation → Deployment → Evidence → Continuous Improvement
One research ecosystem. Multiple applications.
Our patient-facing AI provides a large-scale environment for studying conversational healthcare, patient engagement, multimodal interaction, and responsible medical AI.
Explore ChatDok AppResearch and clinical implementation focus on how AI can support patients and care teams between hospital discharge and recovery across multiple therapeutic pathways.
Explore ChatDok-NavigatorOur flagship clinical research program investigates continuous cardiovascular monitoring, patient engagement, multimodal predictive analytics, and proactive physician oversight for heart failure and coronary artery disease.
Explore ChatDok-HeartThe underlying architecture brings together specialized models, multimodal capabilities, safety mechanisms, and clinical AI components.
Explore CuraThese partnerships enable us to move beyond laboratory benchmarks and evaluate AI in the environments where healthcare actually happens. Our current programs include multi-site clinical research and real-world implementation initiatives.
Clinically useful. Scientifically rigorous. Responsible by design.
Technology should be evaluated by measurable outcomes, not technological novelty alone.
AI should operate within appropriate boundaries and clinical oversight.
Patients and clinicians remain central to the healthcare experience.
Healthcare AI must work with existing healthcare infrastructure.
Research has greater impact when it can move from the laboratory into clinical practice.
2026 - All Rights Reserved.